title: Sunitinib-induced reduction in skin microvascular density is a reversible phenomenon.
authors.affiliation: Department of Internal Medicine.
authors.forename: M P
authors.initials: MP
authors.lastname: de Boer
authors.affiliation: Department of Medical Oncology, VU University Medical Center.
authors.forename: A A M
authors.initials: AAM
authors.lastname: van der Veldt
authors.affiliation: Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands.
authors.forename: N A
authors.initials: NA
authors.lastname: Lankheet
authors.affiliation: Department of Internal Medicine.
authors.forename: N J
authors.initials: NJ
authors.lastname: Wijnstok
authors.affiliation: Department of Medical Oncology, VU University Medical Center.
authors.forename: A J M
authors.initials: AJM
authors.lastname: van den Eertwegh
authors.affiliation: Department of Medical Oncology, VU University Medical Center. Electronic address: e.boven@vumc.nl.
authors.forename: E
authors.initials: E
authors.lastname: Boven
authors.affiliation: Department of Internal Medicine.
authors.forename: E H
authors.initials: EH
authors.lastname: Serné
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D002196:Capillaries / Q000187:drug effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007211:Indoles / Q000494:pharmacology*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010166:Palliative Care; D011758:Pyrroles / Q000494:pharmacology*; D012867:Skin / Q000098:blood supply* / Q000187:drug effects*; D000077210:Sunitinib
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib